Phase 4 Type 2 Diabetes Mellitus Clinical Trials
20 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 20 trials
Recruiting
Phase 4
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana90 enrolled1 locationNCT06613854
Recruiting
Phase 4
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University100 enrolled1 locationNCT07272343
Recruiting
Phase 4
Glycemic Variability of Combination Therapies in T2DM
Type 2 Diabetes Mellitus (T2DM)
JW Pharmaceutical178 enrolled1 locationNCT07442006
Recruiting
Phase 4
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes Mellitus+4 more
Applied Biologics, LLC60 enrolled1 locationNCT07159282
Recruiting
Phase 4
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
T2DM (Type 2 Diabetes Mellitus)
Federico II University80 enrolled2 locationsNCT07314684
Recruiting
Phase 4
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.430 enrolled1 locationNCT07244003
Recruiting
Phase 4
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Type 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection Fraction
The University of Texas Health Science Center at San Antonio78 enrolled1 locationNCT05838287
Not Yet Recruiting
Phase 4
EMPRESS Trial: Assessing the efficacy of EMPagliflozin in REducing Coronary Stent ReStenosis Rates in Type 2 Diabetes
Type 2 Diabetes Mellitus
Northern Health40 enrolled1 locationACTRN12625000924459
Recruiting
Phase 4
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
Diabetic Foot UlcerFoot Ulcer Due to Type 2 Diabetes MellitusUlcer+4 more
Sequence LifeScience, Inc.350 enrolled1 locationNCT07086443
Recruiting
Phase 4
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Cardiovascular DiseasesType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
University of Aarhus80 enrolled1 locationNCT07026539
Not Yet Recruiting
Phase 4
Evaluating the effect of Dapagliflozin on Alanine Transaminase Levels in Type 2 Diabetic Patients with Non Alcoholic Fatty Liver Disease
Non Alcoholic SteatohepatitisType 2 Diabetes Mellitus
MTI Lady Reading Hospital192 enrolled1 locationACTRN12624000039583
Not Yet Recruiting
Phase 4
Evaluating the effect of Dapagliflozin on Proteinuria in Type 2 Diabetic Patients.
Type 2 Diabetes Mellitus
MTI Lady Reading Hospital516 enrolled1 locationACTRN12624000033549
Recruiting
Phase 4
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University150 enrolled1 locationNCT05553093
Recruiting
Phase 4
The effect of a GLP-1 agonist in patients with a dual diagnosis of Parkinson's Disease and Type 2 Diabetes Mellitus
Type 2 Diabetes MellitusParkinson's Disease
St Vincent's Health Network12 enrolled1 locationACTRN12620000627954
Completed
Phase 4
Role of Magnetic Resonance Imaging (MRI) in evaluating the impact of Empagliflozin on kidneys in patients with Type 2 diabetes.
Type 2 Diabetes Mellitus
Austin Health76 enrolled2 locationsACTRN12619000933156
Completed
Phase 4
Improving Glucose Outcomes Using a Novel Treatment Strategy in Young Adult Onset Type 2 Diabetes
Young Adult Onset Type 2 Diabetes Mellitus
Royal Prince Alfred Hospital20 enrolled1 locationACTRN12617000480381
Terminated
Phase 4
Effects and Mechanisms of Action of an Endoscopically Placed Duodenal-Jejunal Sleeve Device (Endobarrier) in Obese Patients with Type II Diabetes
ObesityType 2 Diabetes Mellitus
Princess Alexandra Hospital40 enrolled1 locationACTRN12615001229561
Completed
Phase 3Phase 4
Improved treatment of type 2 diabetes mellitus by improving the splenic functions and gastro intestinal tract using naturally occurring bioactive compounds
gastrointestinal disorderSplenic and gastro intestinal disorder in Type 2 Diabetes Mellitus
Nguyen Van Toan94 enrolled1 locationACTRN12614000007639
Completed
Phase 4
Bromocriptine effect on left ventricular hypertrophy in patients with diabetic nephropathy
Stage IV of chronic kidney diseaseType 2 diabetes mellitus (DM2)
Escuela Superior de Medicina del Instituto Politecnico Nacional (IPN)20 enrolled1 locationACTRN12610000779077
Completed
Phase 4
A study to investigate the effect of taking Nicotinic Acid Prolonged Release on abnormal artery blood vessel function in people with Type 2 diabetes who are on best-dose treatment with statin medications.
Subjects with Type 2 diabetes mellitus who are receiving optimal dose statin therapy.
Professor Gerald Watts50 enrolled1 locationACTRN12606000466549